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Abstract
Background: The aim was to evaluate and validate a bowel disease questionnaire in patients
attending an out-patient gastroenterology clinic in Greece.
Methods: This was a prospective study. Diagnosis was based on detailed clinical and laboratory
evaluation. The questionnaire was tested on a pilot group of patients. Interviewer-administration
technique was used. One-hundred-and-forty consecutive patients attending the out-patient clinic
for the first time and fifty healthy controls selected randomly participated in the study. Reliability
(kappa statistics) and validity of the questionnaire were tested. We used logistic regression models
and binary recursive partitioning for assessing distinguishing ability among irritable bowel syndrome
(IBS), functional dyspepsia and organic disease patients.
Results: Mean time for questionnaire completion was 18 min. In test-retest procedure a good
agreement was obtained (kappa statistics 0.82). There were 55 patients diagnosed as having IBS, 18
with functional dyspepsia (Rome I criteria), 38 with organic disease. Location of pain was a
significant distinguishing factor, patients with functional dyspepsia having no lower abdominal pain
(p < 0.001). Significant factors distinguishing between IBS and functional dyspepsia were relief of
pain by either antacids or defecation (19% vs 71% and 66% vs 0% respectively). Awakening from
pain at night was also a factor distinguishing between IBS and organic disease groups (26% vs 61%,
p < 0.01).
Conclusions: This questionnaire for functional bowel disease is a valid and reliable instrument that
can distinguish satisfactorily between organic and functional disease in an out-patient setting.
Introduction
Functional bowel disorders form a heterogeneous group
of clinical syndromes related to the gastrointestinal tract
that present no histological, endoscopic or imaging ab-
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normalities and are not the result of infectious or meta-
bolic disease. Due to our limited understanding of their
pathogenesis, functional bowel disorders remain largely a
diagnosis of exclusion. This fact, together with a feeling of
uncertainty on the part of the physician, may lead to many
unnecessary and expensive tests and examinations in or-
der to rule out cancer or a possibly serious organic disease
[1,2]. If there is a situation where the medical history
makes an essential contribution towards reaching the cor-
rect diagnosis, this holds true for the patient with func-
tional bowel disorders. The need for simple and valid
diagnostic criteria for these disorders which are best de-
fined by their symptoms, has led to the search of clusters
of positive symptoms that are thought of as characteristic
for patients with functional disorders [3,4]. A symptom-
based diagnostic classification system has recently been
developed by multinational working teams, better known
as Rome Committees, resulting in diagnostic criteria for
functional gastrointestinal disorders [5].
In order to elicit symptoms relevant to functional disor-
ders, the administration of questionnaires has been
proved as valuable. It has been shown that a bowel disease
questionnaire may be of value in the gastroenterology
outpatient setting, where functional bowel symptoms are
commonly reported. Several questionnaires have been
evaluated assessing the two major functional bowel disor-
ders, i.e. the irritable bowel syndrome (IBS) and function-
al dyspepsia (non-ulcer dyspepsia), and trying to
distinguish them both from organic diseases and from
each other [6–8].
The aim of the present study was 1) to evaluate a bowel
disease questionnaire that had been designed for Greek
patients attending an out-patient gastroenterology clinic
and 2) to analyze the data obtained.
Methods
Geography and health system
The island of Crete, which has approximately 550,000 in-
habitants, is divided into four administration prefectures.
Each prefecture has a local hospital but there is only one
tertiary care hospital: the University Hospital, in Herak-
lion. The prefecture of Heraklion has approximately
280,000 inhabitants, of which 150,000 are urban and the
remaining 130,000 are rural residents. The Gastroenterol-
ogy Department of the University Hospital of Heraklion is
the referral centre for gastrointestinal patients of the is-
land. At the same time it fulfils the function of a primary
care centre for subjects with gastrointestinal complaints
who are residents of the prefecture of Heraklion. This is
due to the structure of the Greek National Health System,
according to which subjects from a prefecture are entitled
to attend outpatient clinics of a tertiary care Hospital with-
out referral from their general practitioners or rural physi-
cians.
Questionnaire creation and mode of administration
We created a questionnaire based on the symptom-orient-
ed questionnaire described by Talley et al [9], with several
adaptations, and the consensus Rome I criteria [10]. The
text of symptom-related questions was formulated by a
physician with extensive experience in the management of
gastrointestinal outpatients (NF). Two gastroenterologists
(IM, PS) revised the text and made necessary changes by
eliminating ambiguous questions and expressions in or-
der to get a clear and relevant questionnaire. After reach-
ing the final version, the questionnaire was tested on a
pilot group of 30 out-patients using self-administration
technique. Only 12 out of the 21 returned questionnaire
forms were adequately filled-in so as they could be further
evaluated. In order to get reliable results we decided to
continue the study using the interviewer-administration
technique. Our decision was buttressed by the fact that in
a group of 15 patients where it was possible to use both
administration techniques, we obtained identical results.
The interviewer for all patients was a final year medical
student (AK).
Participants
One-hundred-and-forty consecutive patients attending
the outpatient Gastroenterology clinic of the University
Hospital of Heraklion for the first time and complaining
of abdominal pain, discomfort or disturbed stool move-
ments were invited to provide responses to the question-
naire. There was a refusal rate of 8.6% (12 patients). Fifty
healthy controls were randomly selected from visitors to
the Orthopedic department of the same hospital. None of
them had visited a physician for gastrointestinal symp-
toms during the last three years. After one to two weeks,
the questionnaire was given to be completed for a second
time in 12 patients whose symptoms remained stable dur-
ing this period and in 6 controls in order to check for the
concordance of the answers (reliability). After a period of
one to three month of clinical evaluation and follow up,
a diagnosis was provided by two experienced gastroenter-
ologists (IM, NF). Responses to the questionnaire were
not used for the final diagnosis. Healthy controls did not
undergo any clinical tests. The final diagnosis was made
independently of the questionnaire responses and was
based on the results of the clinical and laboratory investi-
gation. All patients underwent endoscopic evaluation of
upper or/and lower digestive tract, and ultrasound of up-
per abdomen, while CT scan was performed when need-
ed. The Rome I diagostic criteria as described in [10] were
used, consisting for IBS in the followings: at least 3
months of continuous or recurrent symptoms of 1. Ab-
dominal pain or discomfort that is a) relieved with defe-
cation; and/or b) associated pain with a change inBMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/8
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frequency of stool and/or c) associated with a change in
consistency of stool; and/or 2. Two or more of the follow-
ing, at least one-fourth of occasions or days: a)altered
stool frequency; b)altered stool form;c)altered stool pas-
sage; d)passage of mucus; e) bloating or feeling of abdom-
inal distention [10]. Patients were reached by telephone
call 1.5–2 years after diagnosis for a further confirmation
of the final diagnosis. In four cases no conclusive diagno-
sis was reached. Fourteen patients were lost to follow-up.
Statistical analysis
Pearson's chi-square tests were performed to assess wheth-
er the patients differed from the control subjects with re-
spect to qualitative sociodemographic variables. The
factors assessed were gender, marital status, occupation,
birth rank, educational and area of residence. Compari-
sons of the age distribution between patients and controls
were made using the Student's t-test. One-way analysis of
variance (one-way ANOVA) was used to assess possible
differences in age distribution between the patient groups.
Subsequently, the applicability of the bowel disease ques-
tionnaire in distinguishing between the three bowel dis-
ease groups was investigated. Initially, logistic regression
models were fitted to examine differences in responses be-
tween the disease groups for each of the questionnaire
items separately, having adjusted for possible age and sex
effects. The significance of each of the factors was ob-
tained by calculating the decrease in deviance when the
factor was included in the model (given the null model in-
cluding age and sex only) and comparing this to the ap-
propriate chi-square distribution. In those questions
involving abdominal pain, a separate category was includ-
ed within each item for those patients who did not re-
spond that they had abdominal pain more than six times
in the previous year.
In order to determine whether the three patient groups
could be separated on the basis of their questionnaire re-
sponses, classification rules for the diagnostic groups
based on patient responses were derived. Models were fit-
ted using binary recursive partitioning. With these classifi-
cation models, the initial split is on the most significant
predictor and the construction method chooses the next
split in an optimal way. In order to determine whether the
model could be made more parsimonious without sacri-
ficing its goodness-of-fit, the least important splits were
removed using the cost-complexity measure Dα (T')=D(T')
+ a size(T'), where D(T') is the deviance of sub-tree T',
size(T') is the number of terminal nodes of T' and a is the
cost-complexity parameter. For the present study, with
three classification groups, taking a = 4 enables one to find
the subtree with minimum Akaike's Information Criteri-
on, (this criterion penalizes minus twice the log-likeli-
hood by twice the number of independent parameters)
[11]. Finally, cross-validation was performed by splitting
the data into ten mutually exclusive sets.
The test-retest reliability of the questionnaire was judged
with the use of the Kappa statistic to assess concordance
between questionnaire responses on two separate occa-
sions. A kappa value of 1 corresponds to a perfect con-
cordance and a value of 0 to a concordance not different
from chance [12].
The statistical packages used were SPSS version 7.5 and S-
Plus (version 4.5).
Results
The mean time for interview and completion of the ques-
tionnaire was 18 minutes. The subjects who participated
understood and answered the questions easily. On re-test-
ing, which was performed on 18 persons at an interval of
7–14 days, significant agreement on all answers was ob-
tained. Median kappa statistic for all questions was 0.82
(range 0.56 to 1.0).
There were 55 patients diagnosed as having IBS, 18 pa-
tients with functional dyspepsia, both groups according to
the Rome criteria [13], and 38 patients with organic dis-
ease (14 with peptic ulcer or gastroesophageal reflux dis-
ease, 7 with diseases of the biliary tract, 6 with
inflammatory bowel disease, 2 with self-limited infectious
colitis, 3 with bacterial overgrowth syndrome, and the re-
maining 6 patients with various diseases, among these 2
malignancies: cancer of the ampulla of Vater, and of the
colon). The one patient who was diagnosed as having
both functional dyspepsia and organic disease was exclud-
ed from the statistical analysis. Also excluded were the 18
subjects that did not completed the evaluation (14 lost to
follow-up and 4 with no conclusive diagnosis).
The demographic characteristics of the patients and con-
trols are presented in Table 1. There was no significant dif-
ference in age or in sex ratios between patients (median
age 54 years, 43% males) and controls (median age 50
years, 58% males). More patients than expected (p <
0.0005) were educated at most to primary level; 74% of
patients (95 observed, 85 expected) compared to 46% (23
observed, 33 expected) of the control group (υ 2 = 12.81
on 1 df). Also, more than expected patients came from ru-
ral areas (p = 0.012), 73 observed versus 65 expected (υ 2
= 6.4 on 1 df). The homogeneity between the patient
groups with regard to their demographic characteristics is
indicated by the percentages presented in Table 1. The
only significant difference between groups was with re-
spect to age distribution, with organic disease patients be-
ing older than those suffering from IBS (p = 0.002).BMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/8
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The prevalence of symptoms in the subgroups of patients
with IBS, functional dyspepsia and organic disease and
also in the control group is presented in table 2. Having
had abdominal pain on at least six occasions in the previ-
ous year was a very common symptom (over 88%) in eve-
ry disease group. It can be seen that the location of the
abdominal pain is a significant distinguishing factor, with
patients with functional dyspepsia having no lower ab-
dominal pain (p < 0.001). Other significant factors distin-
guishing the IBS from the functional dyspepsia group
were whether there was pain relief by antacids (19% in
IBS, 71% in functional dyspepsia patients), whether pain
was relieved on defecation (66% in IBS, 0 in functional
dyspepsia patients) and having more stools when the pain
began (49% in IBS, 6% in functional dyspepsia patients).
For the IBS versus organic disease comparisons, awaking
from the pain at nighttime was significantly more often
present in patients with organic disease (26% in IBS, 61%
in organic disease patients, p < 0.01).
An example of classification using the model provided in
fig. 1 is as follows: a subject aged 45 presenting with pain
in the lower abdomen which he/she has had for less than
two years, feeling bloated, the pain not being related to
eating a meal, would be classified as having IBS (with a
probability greater than 0.99) as opposed to having func-
tional dyspepsia or organic disease. If the same subject
stated that the pain was related to eating a meal, he/she
would again be classified as having IBS using the model,
but the probability is now 0.625 versus 0.375 of having
organic disease. When the model in fig. 1 was subjected to
cost-complexity pruning, the pruned model had nine ter-
minal nodes, with the splits following the pain reflection
question now not included (i.e. feeling bloated and the
subject's age). The cost of increasing the simplicity of the
model was that the misclassification rate rose from 20%
to 24%. Cross-validation that was performed on the mod-
el indicated that perhaps the most important questions
contained in the questionnaire were the presence and lo-
cation of the abdominal pain and having loose bowel
movements.
Discussion
In this study we evaluated a questionnaire that was devel-
oped for patients attending a Gastroenterology out-pa-
tient Clinic in Greece. In the design of our questionnaire
several instruments proposed by other authors were taken
into account [4,8,14–19]. As most of these studies were
performed in selected populations, the question has been
already raised whether the results might not be represent-
ative for persons belonging to other groups [20]. We in-
tended to elaborate an instrument that could differentiate
among patients with functional dyspepsia, irritable bowel
syndrome and organic gastrointestinal disease. We had to
adapt our instrument for use within the Greek linguistic
and cultural milieu. To provide a disease questionnaire
for respondents belonging to other groups requires adap-
tation, modification and establishing its validity within a
different cultural context [21].
In the present study we took these steps under the guid-
ance of a panel of physicians familiar with functional
bowel disease. The instrument was validated in subjects
having an open access to a Gastroenterology Department
and coming from a referral area of 250.000 inhabitants,
both rural and urban. Rural residents and subjects with
only primary educational level were met more often in the
patients' group than in that of healthy controls, the latter
consisting of visitors to hospitalized patients. This fact re-
flects the constitution of the patients' group, which was
representative of the whole referral area, in contrast to the
controls who came from the urban area of the Hospital.
Table 1: Demographic characteristics of patients and controls answering bowel disease questionnaires
Irritable bowel   
syndrome patients
Functional dys-
pepsia patients
Organic dis-
ease patients
Patients lost to 
follow-up
All Patients Control group
Number of subjects 55 17 37 14 128 50
Sex
male (%) : female (%) 18 (33) : 37 (67) 9 (53) : 8 (47) 19 (51) : 18 (49) 7 (50) : 7 (50) 56 (43) : 72 (57) 29 (58) : 21 (42)
Residence
rural (%) 34 (62) 8 (47) 23 (62) 6 (43) 73 (57) 18 (36)
Education
none or primary (%) 39 (71) 14 (82) 29 (78) 11 (79) 95 (74) 23 (46)
Age, median (mean, SE) 46 (49, 1.6) 58 (56, 3.3) 63 (58, 2.8) 54 (56, 4.3) 54 (53, 1.3) 50 (48, 2.5)
sOf the 128 patients who agreed to participate and answered the questionnaire, no conclusive diagnosis was reached for four subjects and one per-
son diagnosed as having both dyspepsia and organic disease was omitted from the study. The only evidence of a difference between the patient 
groups for the demographic variables was in the age distributions. *p < 0.05, chi-square **p < 0.0005, chi-square testBMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/8
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Besides, the control group represented a random sample
of the population, thus explaining the fact that several of
the controls met the Rome IBS criteria. It has to be re-
minded that surveys of Western populations have re-
vealed IBS in 15–20% of adolescents and adults [22].
Due to a low yield of answered questionnaires when self-
administered mode was first undertaken, we used the in-
terviewer-administered technique. All respondents under-
stood the items without difficulty. The instrument was
shown to discriminate well among the disease groups of
organic disease, functional dyspepsia and irritable bowel
syndrome. For reasons of consistency and applicability of
the results of this study, we used the Rome I criteria for IBS
[10]. The questionnaire for functional bowel disease was
shown to be reliable: persons who were asked at two dif-
ferent occasions gave comparable answers.
Concerning the symptoms differentiating between IBS
and functional dyspepsia, the most important features in
our patients were 1) the location of pain, 2) whether the
pain was relieved on defecation or by antacids and 3)
whether there were more stools when the pain began. In
distinguishing between IBS and organic disease, the most
prominent features were the awaking from the pain at
night and whether the pain was relieved by defecation or
antacids. Our results, and especially the criterion referring
to pain being relieved by defecation, can be considered as
a further validation of the Rome II criteria distinguishing
IBS from other groups [22].
When trying to interpret our results, the recursive parti-
tioning model offers the advantage of simplification. Fig-
ure 1 is a graphical representation of the model used to
discriminate between the three disease groups forming
the hospital outpatient sample. The discrimination rules
and corresponding probabilities of being in each disease
group are presented. There are 13 terminal nodes. The
model has a correct classification rate of 80% (22 patients
misclassified out of 109). The most significant binary split
in the discrimination process is the question related to the
location of abdominal pain, and more specifically wheth-
er pain is present in the upper abdomen. On the basis of
this question alone, the model splits the patients in two
groups: those with either IBS or organic disease and those
with functional dyspepsia or organic disease. The other
significant factors in distinguishing between possible IBS
and organic disease patients are the age of the subject, the
duration of time for which they have had such a pain, the
feeling of bloatedness, the frequency of the pain and
whether pain is relieved on defecation.
Figure 1
A graphical depiction of the recursive partitioning model classifying gastrointestinal patients as having IBS, functional dyspepsia
or organic disease based on responses to a bowel disease questionnaire.
|
LOCATION OF PAIN
STOOLS USUALLY WATERY?
PAIN REFLECTION
ABDOMINAL DISTENSION?
AGE<54.5 yrs
AGE<66.5 yrs
AGE  <64.5 years
PAIN FOR HOW MANY YEARS?
ABDOMINAL DISTENSION?
PAIN FREQUENCY
3 3
2 32
3
1
3 1
313
Upper abdomen
GROUP
1 IBS 
2 Functional dyspepsia
3 Organic disease
No No Yes
Spine
Elsewhere/no reflection
No
Yes
Yes No
Yes No
>2 yrs <=2 yrs or n/a
No Yes
>=once a 
week
<once a week 
or n/a
PN RLF DFCTN?#
#PN RLF DFCTN?= Pain relief on defecation?
Lower abdomen or 
entire abdominal area or n/a*
*n/a = question is not applicable i.e. patient has not had abdominal pain at least 6 times in the previous year
No or n/a YesBMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/8
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Table 2: Prevalence of signs and symptoms in patients with IBS, functional dyspepsia or organic disease and controls, and comparisons 
of IBS with dyspepsia and organic disease patients using logistic regression models.
IBS (n = 55) Functional dys-
pepsia (n = 17)
Organic disease 
(n = 37)
Healthy con-
trols (n = 50)
IBS vs Dyspep-
sia
IBS vs Organic 
Disease
%%%%×  2statistic (change 
df), p-value
×  2statistic (change 
df), p-value
Abdominal pain >6 
times last year
96 100 89 36 ns ns
Location of pain*:
Upper abdomen 4 94 55 50 58.01 (2), p           
< 0.0001
32.70 (2), p 
< 0.001
Lower abdomen 45 0 15 22 17.70 (2), p 
< 0.001
30.42 (2), p 
< 0.001
All abdomen 51 6 30 28 13.33 (2), p 
< 0.001
12.87 (2), p 
< 0.001
Presence of pain*:
<1 year 34 29 55 28 ns ns
< 2  y e a r s 1 72 41 81 7n sn s
> 2  y e a r s 4 94 72 75 6n sn s
Duration of pain*:
> 6  h o u r s 4 03 53 91 7n sn s
Frequency of pain*:
> once a week 74 77 70 22 ns ns
Pain reflection*:
No reflection 73 70 61 88 ns ns
Spine 6 12 21 6 ns ns
Hips 13 6 12 6 ns ns
Elsewhere 8 12 6 0 ns ns
Night pain (wakes 
subject)*
26 71 61 28 9.76 (2), p < 0.01 9.48 (2), p < 0.01
Pain relieved by 
antacids*
19 71 36 50 17.48 (2), p 
< 0.001
6.06 (2), p < 0.05
Pain affected by 
eating*
30 77 46 50 13.13 (2), p < 0.01 ns
Pain appears after 
meal*
21 47 36 22 7.30 (2), p < 0.05 ns
Pain alleviated by 
eating*
6 24 6 33 ns ns
Pain made worse 
by eating*
19 41 21 11 ns ns
Pain relieved by 
defecation*
66 0 39 33 29.05 (2), p 
< 0.001
7.24 (2), p < 0.05
More stools when 
pain begins*
49 6 30 17 14.82 (2), p 
< 0.001
ns
Looser stools 
when pain begins*
53 6 33 17 13.72 (2), p 
< 0.05
ns
Pain worse after 
defecation*
4000n s n s
Change noticed in 
bowel habits in the 
last year
24 6 35 4 3.91 (1), p <
 0.05
ns
>3 bowel move-
ments/day
16 0 35 4 6.46 (1), p < 0.05 ns
<3 bowel move-
ments/week
20 18 11 20 ns ns
Have both consti-
pation and diar-
rhoea
24 12 16 6 ns ns
Take medication 
for constipation
16 6 11 6 ns nsBMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/8
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Having determined the localization of pain, significant
factors in distinguishing between possible functional dys-
pepsia and organic disease are the presence of loose
stools, whether or not there was reflection of pain to the
spine, the presence of bloating and the age of the subject.
An important advantage of the recursive partitioning ap-
proach over logistic regression is that enables the IBS,
functional dyspepsia and organic disease groups to be
modeled simultaneously. At the same time, the rules de-
rived are easy to interpret. A summary of the rules derived
from the model is provided in Additional File:Appendix.
There are a few drawbacks in this study, some of them be-
ing shared with similar studies. The model we used as-
sumes that patients fall into exactly one of the three
categories, excluding the possibility that a patient may not
have any of the three conditions or may have two of them.
In fact, only one patient in this study had both organic
and functional disease. As this coincidence may not be a
rarity in other, differently selected, populations, it consti-
tutes a drawback of this kind of model. A more important
point may be the finding that the results of bowel disease
questionnaires were not reproduced in comparable and
unselected populations [23]. Therefore, the diagnostic
value of our instrument may also have little external valid-
ity. A further drawback of this study may be the small
number of the sample, especially the group with function-
al dyspepsia. This fact may influence the validity of the
comparisons concerning functional dyspepsia but not
those concerning functional as opposed to organic diseas-
es. At last, self-administration of the questionnaire, a
process that is considered both unbiased for the patient
and time-saving for the doctor, was not feasible in the
context of this study. None the less, the interview tech-
nique proved to be time-saving and to give a better yield
of answers and a minimal rate of uncompleted questions.
In conclusion, our study showed that the questionnaire
for functional bowel disease we have developed is a valid
and reliable instrument in the particular cultural and lin-
guistic setting of Greek patients. This questionnaire can
distinguish satisfactorily between organic and functional
disease. The classification oriented model derived from
the evaluation of the results obtained is easy to interpret
and it could be used in the out-patient setting.
Conpeting interests
None declared.
Stools often hard 40 41 27 20 ns ns
Have difficulty def-
ecating
51 29 30 14 ns ns
Stools often loose 
& watery
38 12 38 10 5.07 (1), p < 0.05 ns
Feeling of incom-
plete emptying
47 12 32 4 9.22 (1), p < 0.01 ns
Often feel that 
can't delay defeca-
tion
36 18 35 8 4.14 (1), p < 0.05 ns
Passage of mucus 27 0 24 2 7.48 (1), p < 0.01 ns
See blood on defe-
cation:
3 16 2 41 4n sn s
when wiping 29 6 22 14 ns ns
in stools 15 6 16 2 ns ns
Have haemor-
rhoids
36 12 24 16 ns ns
Need to defecate 
wakes subject
9 6 22 0 ns ns
I n c o n t i n e n c e 4030n s n s
Abdominal disten-
sion
82 88 51 28 ns 5.58 (1), p < 0.05
Have previously 
visited physician 
for one of the 
problems men-
tioned
86 94 70 12 ns ns
*For pain related questions, the percentages displayed are the percentages of those subjects who have the pain symptom (55 IBS, all 17 functional 
dyspepsia, 33 organic disease, 18 controls)
Table 2: Prevalence of signs and symptoms in patients with IBS, functional dyspepsia or organic disease and controls, and comparisons 
of IBS with dyspepsia and organic disease patients using logistic regression models. (Continued)BMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/8
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